Skip to content

Enhanced Recovery After Cardiac Surgery

Feasibility of Delivering Enhanced Recovery After Cardiac Surgery

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03859102
Acronym
ERAS
Enrollment
80
Registered
2019-03-01
Start date
2018-12-17
Completion date
2019-11-29
Last updated
2019-09-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Aortic Root Dilatation, Aortic Valve Disease, Cardiac Surgery, Coronary Artery Disease, Mitral Valve Disease, Tricuspid Valve Disease

Keywords

Enhanced recovery after Surgery, ERAS, Enhanced Recovery after Cardiac Surgery, Cardiac Surgery, Coronary Artery Bypass graft, Aortic Valve Surgery, Mitral Valve Surgery, Aortic Root Surgery

Brief summary

Enhanced Recovery Protocols (ERPs or bundles) have been established in many surgical specialties (such as colon cancer and orthopaedic joint surgeries) for several years in hospitals worldwide. The principles of Enhanced Recovery Protocols are those of early mobilization and restoration of normal function as soon as possible after surgery. These principles are achieved by use of alternate pain control regimens and removing invasive lines and drains as soon as possible. The benefits of ERPs are improved patient experience, earlier return to normal function and reduced length of stay. Enhanced recovery protocols for cardiac surgery have been published by the Enhanced Recovery After Cardiac Surgery Society. The current study will investigate whether it is possible to utilise ERP bundles in the population of cardiac surgery patients at James Cook Hospital, with a view to rolling out a full ERP service. Secondary study outcomes will be patient-centred, including; pain scores, nausea and vomiting rates and time taken to return to normal function.

Detailed description

Why? Enhanced Recovery Protocols (ERPs or bundles) have been established in many surgical specialties (such as colon cancer and orthopaedic joint surgeries) for several years in hospitals worldwide. The principles of Enhanced Recovery Protocols are those of early mobilization and restoration of normal function as soon as possible after surgery. These principles are achieved by use of alternate pain control regimens and removing invasive lines and drains as soon as possible. The benefits of ERPs are improved patient experience, earlier return to normal function and reduced length of stay. Enhanced recovery protocols for cardiac surgery have been published by the Enhanced Recovery After Cardiac Surgery Society. These protocols have been demonstrated as safe, though have yet to make it into mainstream practice in the UK. The use of ERPs in Cardiac Surgery has the potential to greatly improve the patient journey and hospital efficiency. What? The current study will investigate whether it is possible to utilise ERP bundles in the population of cardiac surgery patients at James Cook Hospital, with a view to rolling out a full ERP service. Secondary study outcomes will be patient-centred, including; pain scores, nausea and vomiting rates and time taken to return to normal function. Who? All adult patients over the age of 18 years and listed for cardiac surgery will be considered for inclusion in this study. Where? The study population will be comprised of patients undergoing cardiac surgery at the James Cook University Hospital in Middlesbrough. How? Study duration will be 6 months, with 80 patients (comprising a control and intervention group)

Interventions

DIETARY_SUPPLEMENTPre-operative Carbohydrate PreLoad drink

Pre-operative Carbohydrate PreLoad drink, 1 sachet given the night before surgery. One sachet given 2-4hours before surgery.

One dose of Gabapentin pre-operatively, 300mg orally.

DRUGOral Lansoprazole pre-op

One dose of Lansoprazole pre-operatively, 30mg orally.

DRUGIntravenous Paracetamol intra-operatively

One dose of Paracetamol intra-operatively, 1gram intravenous infusion.

DRUGIntravenous Dexamethasone intra-operatively

One dose of Dexamethasone intra-operatively as an anti-emetic, 8mg intravenous.

DRUGIntravenous Ondansetron intra-operatively

One dose of Ondansetron intra-operatively as an anti-emetic, 4mg intravenous

DRUGInfiltration of surgical wounds with local anaesthetic

Infiltration of surgical wounds with local anaesthetic at the end of surgery, Bupivacaine 1-2mg/kg.

DRUGIntravenous Magnesium intra-operatively

One infusion of intravenous Magnesium Sulphate intra-operatively as an analgesic, 50mg/kg given over 30minutes.

DRUGPost-operative Gabapentin analgesia

Post-operative oral Gabapentin 300mg, three times daily as an analgesic.

DRUGPost-operative oral Paracetamol analgesia

Post-operative Paracetamol as an analgesic. Initially intravenously, then orally. One gram four times daily.

DRUGPost-operative Ondansetron anti-emesis

Intravenous Ondansetron administered post-operatively as prophylactic anti-emesis. 4mg three times daily, for 24 hours. Then as required.

Removal of the endotracheal tube in the Intensive Care Unit as soon as is safe.

PROCEDUREEarly mobilisation/physiotherapy

Mobilisation (active and passive limb movements, deep breathing) with the assistance of nurse/physiotherapist to occur as soon as possible post-operatively.

OTHEREncourage early oral food intake

Patients will be encouraged to start eating as soon as possible post-operatively

Sponsors

Medela AG
CollaboratorINDUSTRY
James Cook University Hospital
Lead SponsorOTHER

Study design

Allocation
NON_RANDOMIZED
Intervention model
SEQUENTIAL
Primary purpose
TREATMENT
Masking
NONE

Intervention model description

Sequential prospective cohort study

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Having Cardiac Surgery * Aged 18 years or older at the time of consent * Deemed appropriate for ERAS by Surgeon and Anaesthetist * Able and willing to provide written informed consent

Exclusion criteria

* Aged 18 years or under * Deemed not suitable for ERAS by Surgeon and/or Anaesthetist

Design outcomes

Primary

MeasureTime frameDescription
ERAS bundle compliance in the first 48hours post-op48hours post opNumber of interventions for the ERAS protocol that are delivered to patient (numeric data e.g. 6 out of 10)

Secondary

MeasureTime frameDescription
Time to extubation0-24hoursTime taken until patient extubated (ETT) post op (in minutes)
Time to mobilisation0-48hoursFirst mobilisation with nurse/physiotherapist post-op (in minutes)
Time to oral diet0-48hoursTime until patient first eats post-op (in minutes)
Post-op pain6hoursPain scores at 6hours, Numeric scale 0 (no pain) - 10 (severe pain)
Quality of Recovery6 weeks post surgeryQuantification of patient quality of recovery. Using Q-o-R 15 Scale internationally validated scale. This allows the patient to report on a numerical scale from 0 (not at all) to 10 (all of the time); the patients scores on aspects of recovery such as pain at rest, pain on movement, quality of sleep, presence of nausea and vomiting, feeling supported by medical staff.

Countries

United Kingdom

Contacts

Primary ContactJim C Coates, MBBS
james.coates1@nhs.net01642854630
Backup ContactAdrian Mellor, MBBS
adrian.mellor@nhs.net01642850850

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026